P.P. Sfikakis

1.2k total citations
32 papers, 806 citations indexed

About

P.P. Sfikakis is a scholar working on Pharmacology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P.P. Sfikakis has authored 32 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P.P. Sfikakis's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). P.P. Sfikakis is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). P.P. Sfikakis collaborates with scholars based in Greece, United States and Netherlands. P.P. Sfikakis's co-authors include Alexios Iliopoulos, Christos Kittas, Antonia Elezoglou, A. Stratigos, Helen Giamarellou, George C. Tsokos, G. Petrikkos, Myron Mavrikakis, S Papazoglou and Petros P. Sfikakis and has published in prestigious journals such as The American Journal of Medicine, European Heart Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P.P. Sfikakis

28 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.P. Sfikakis Greece 16 217 216 189 163 140 32 806
Joaquín Borrás‐Blasco Spain 15 172 0.8× 156 0.7× 135 0.7× 110 0.7× 55 0.4× 61 618
William Barchuk United States 10 220 1.0× 79 0.4× 85 0.4× 348 2.1× 28 0.2× 22 677
Motoi Uchino Japan 26 114 0.5× 64 0.3× 225 1.2× 633 3.9× 76 0.5× 158 1.9k
C Aguirre Spain 10 251 1.2× 665 3.1× 21 0.1× 152 0.9× 269 1.9× 16 1.0k
Cristiano Caruso Italy 23 113 0.5× 258 1.2× 843 4.5× 90 0.6× 59 0.4× 83 1.5k
Giorgia Montrucchio Italy 18 109 0.5× 20 0.1× 88 0.5× 273 1.7× 53 0.4× 61 994
Saime Paydaş Türkiye 14 60 0.3× 68 0.3× 43 0.2× 52 0.3× 78 0.6× 111 745
Tomás S. Bocanegra United States 16 111 0.5× 212 1.0× 128 0.7× 148 0.9× 61 0.4× 34 1.4k
Emmanuel E. Douzinas Greece 18 133 0.6× 20 0.1× 140 0.7× 319 2.0× 75 0.5× 40 1.0k
H Stein Canada 18 105 0.5× 380 1.8× 45 0.2× 158 1.0× 170 1.2× 31 898

Countries citing papers authored by P.P. Sfikakis

Since Specialization
Citations

This map shows the geographic impact of P.P. Sfikakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P. Sfikakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P. Sfikakis more than expected).

Fields of papers citing papers by P.P. Sfikakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.P. Sfikakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P. Sfikakis. The network helps show where P.P. Sfikakis may publish in the future.

Co-authorship network of co-authors of P.P. Sfikakis

This figure shows the co-authorship network connecting the top 25 collaborators of P.P. Sfikakis. A scholar is included among the top collaborators of P.P. Sfikakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.P. Sfikakis. P.P. Sfikakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Παππά, Μαρία, Theodoros Dimitroulas, Charalampos Papagoras, et al.. (2023). POS1152 ATTAINMENT OF EULAR/ERA-EDTA TREATMENT TARGETS IN THE FIRST YEAR IN LUPUS NEPHRITIS: A MULTICENTER OBSERVATIONAL STUDY. Annals of the Rheumatic Diseases. 82. 907–907.
3.
Mavrikakis, Myron, et al.. (2009). Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study. Experimental and Clinical Endocrinology & Diabetes. 106(1). 35–40. 1 indexed citations
4.
Sfikakis, P.P., Alexios Iliopoulos, Antonia Elezoglou, Christos Kittas, & A. Stratigos. (2005). Psoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reaction. Arthritis & Rheumatism. 52(8). 2513–2518. 207 indexed citations
5.
Sfikakis, P.P., Lisa DeTora, Sumiko Shingo, et al.. (2002). A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis. Scandinavian Journal of Rheumatology. 31(4). 230–238. 30 indexed citations
6.
Polyzos, Aristidis, Christos Kosmas, Νicolas Tsavaris, et al.. (2000). Doxorubicin plus Ifosfamide as Salvage Treatment for Patients with Advanced Breast Cancer Refractory to Epirubicin plus Cyclophosphamide. Clinical Drug Investigation. 19(5). 349–355. 2 indexed citations
7.
Mavrikakis, Myron, et al.. (1996). Retinal toxicity in long term hydroxychloroquine treatment.. Annals of the Rheumatic Diseases. 55(3). 187–189. 69 indexed citations
8.
Sfikakis, P., et al.. (1995). Cd28 expression on t cell subsets in vivo and cd28‐mediated t cell response in vitro in patients with rheumatoid arthritis. Arthritis & Rheumatism. 38(5). 649–654. 25 indexed citations
9.
Kanellakopoulou, K., et al.. (1993). Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery. European Journal of Clinical Microbiology & Infectious Diseases. 12(6). 449–453. 44 indexed citations
10.
Galanakis, N., et al.. (1993). Oral Pefloxacin and Ofloxacin in the Treatment of Malignant External Otitis. Drugs. 45(Supplement 3). 320–321. 1 indexed citations
11.
Sfikakis, Petros P., Michael Kyriakidis, Gregory P. Vyssoulis, et al.. (1991). Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. The American Journal of Medicine. 90(1). 541–546. 23 indexed citations
12.
Giamarellou, Helen, et al.. (1991). Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic Gram-negative infections. Journal of Antimicrobial Chemotherapy. 27(suppl C). 73–79. 50 indexed citations
13.
Sfikakis, Petros P., Michael Kyriakidis, Gregory P. Vyssoulis, et al.. (1991). Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. The American Journal of Medicine. 90(5). 541–546. 32 indexed citations
14.
Katsilambros, Nicholas, et al.. (1990). Recovery from insulin-induced hypoglycemia after saccharose or glucose administration.. PubMed. 8(5). 267–72. 15 indexed citations
15.
Sfikakis, Petros P., et al.. (1990). Diffusing capacity of the lung and nifedipine in systemic sclerosis. Arthritis & Rheumatism. 33(11). 1634–1639. 22 indexed citations
16.
Giamarellou, Helen, et al.. (1990). Pharmacokinetics of Three Newer Quinolones in Pregnant and Lactating Women. Obstetrical & Gynecological Survey. 45(10). 684–685. 3 indexed citations
17.
Giamarellou, Helen, et al.. (1989). Pharmacokinetics of three newer quinolones in pregnant and lactating women. The American Journal of Medicine. 87(5). S49–S51. 101 indexed citations
18.
Poularas, John, et al.. (1988). The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin.. PubMed. 7(4). 253–5. 4 indexed citations
19.
Malamos, B., et al.. (1968). Estimation of uricosuric activity of sulfinpyrazone in healthy adults.. PubMed. 27(3). 125–8. 1 indexed citations
20.
Papavasiliou, C. & P.P. Sfikakis. (1964). Tumour-simulating Intrathoracic Marrow Heterotopia in Thalassaemia Major. Thorax. 19(2). 121–124. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquín Borrás‐Blasco Breakdown of academic impact, for papers by William Barchuk Breakdown of academic impact, for papers by Motoi Uchino Breakdown of academic impact, for papers by C Aguirre Breakdown of academic impact, for papers by Cristiano Caruso Breakdown of academic impact, for papers by Giorgia Montrucchio Breakdown of academic impact, for papers by Saime Paydaş Breakdown of academic impact, for papers by Tomás S. Bocanegra Breakdown of academic impact, for papers by Emmanuel E. Douzinas Breakdown of academic impact, for papers by H Stein
Rankless by CCL
2026